77 research outputs found
Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½Π°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΡΠΎΡΡΠ°Π²Π° ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΡΠ»ΡΡ-ΠΏΠΈΡΠΎΠ»ΠΈΠ·Π° ΡΡΠ°ΠΊΡΠΈΠΉ ΡΠΌΠΎΠ» ΠΈ Π°ΡΡΠ°Π»ΡΡΠ΅Π½ΠΎΠ² ΡΡΠΈΠ½ΡΠΊΠΎΠΉ Π½Π΅ΡΡΠΈ
Π£Π·ΠΊΠΈΠ΅ ΡΡΠ°ΠΊΡΠΈΠΈ ΡΠΌΠΎΠ» ΠΈ Π°ΡΡΠ°Π»ΡΡΠ΅Π½ΠΎΠ² Π½Π΅ΡΡΠΈ Π£ΡΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΡΠΎΡΠΎΠΆΠ΄Π΅Π½ΠΈΡ (ΡΠ΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ° ΠΠΎΠΌΠΈ), ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄ΡΠΎΠ±Π½ΡΠΌ ΠΎΡΠ°ΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π°ΡΡΠ°Π»ΡΡΠ΅Π½ΠΎΠ² ΠΈ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ°Π·Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΠΌΠΎΠ», ΠΎΡ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Ρ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ ΠΏΠΈΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π² Π²Π°ΡΠΈΠ°Π½ΡΠ΅ "Rock Eval" ΠΈ ΡΠ»ΡΡ-ΠΏΠΈΡΠΎΠ»ΠΈΠ·Π° (650 Β°Π‘, 20 Ρ) Ρ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π°Π½Π°Π»ΠΈΠ·ΠΎΠΌ Π»Π΅ΡΡΡΠΈΡ
ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² Π² ΡΠ΅ΠΆΠΈΠΌΠ΅ "on line". ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΈΠ·ΡΡΠ΅Π½Π½ΡΠ΅ ΠΎΠ±ΡΠ°Π·ΡΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Ρ ΠΎΡ 2,3 Π΄ΠΎ 15,3 ΠΌΠ°Ρ. % Π½ΠΈΠ·ΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ. ΠΡΠΎΠ΄ΡΠΊΡΡ ΡΠ»ΡΡΠΏΠΈΡΠΎΠ»ΠΈΠ·Π° ΠΈΠ·ΡΡΠ΅Π½Π½ΡΡ
ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² ΠΎΡΠ»ΠΈΡΠ°ΡΡΡΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ΠΌ ΡΠ°ΠΊΠΈΡ
ΡΠΈΠΏΠΎΠ² ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ, ΠΊΠ°ΠΊ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠ΅ ΠΈ ΠΈΠ·ΠΎΠΏΡΠ΅Π½ΠΎΠΈΠ΄Π½ΡΠ΅ Π°Π»ΠΊΠ°Π½Ρ, ?-ΠΎΠ»Π΅ΡΠΈΠ½Ρ, ΡΠΈΠΊΠ»ΠΎΠ³Π΅ΠΊΡΠ°Π½Ρ, Ρ
Π΅ΠΉΠ»Π°Π½ΡΠ°Π½Ρ ΠΈ Π³ΠΎΠΏΠ°Π½Ρ, Π³ΠΎΠΏΠ΅Π½Ρ, ΠΏΡΠ΅Π³Π½Π°Π½Ρ ΠΈ ΡΡΠ΅ΡΠ°Π½Ρ, Π°Π»ΠΊΠΈΠ»Π±Π΅Π½Π·ΠΎΠ»Ρ, Π½Π°ΡΡΠ°Π»ΠΈΠ½Ρ, ΡΠ΅Π½Π°Π½ΡΡΠ΅Π½Ρ ΠΈ Π°Π½ΡΡΠ°ΡΠ΅Π½Ρ, Π±Π΅Π½Π·ΠΎ- ΠΈ Π΄ΠΈΠ±Π΅Π½Π·ΠΎΡΠΈΠΎΡΠ΅Π½Ρ, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π΅ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠΎΠΊΡΠΎΠΎΠ±ΡΠ°Π·ΡΡΡΠΈΡ
ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ²
Homotopy on spatial graphs and generalized Sato-Levine invariants
Edge-homotopy and vertex-homotopy are equivalence relations on spatial graphs
which are generalizations of Milnor's link-homotopy. Fleming and the author
introduced some edge (resp. vertex)-homotopy invariants of spatial graphs by
applying the Sato-Levine invariant for the constituent 2-component
algebraically split links. In this paper, we construct some new edge (resp.
vertex)-homotopy invariants of spatial graphs without any restriction of
linking numbers of the constituent 2-component links by applying the
generalized Sato-Levine invariant.Comment: 16 pages, 13 figure
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
BackgroundInflammatory mammary cancer (IMC), the counterpart of human inflammatory breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack specific therapy and have poor outcomes. This proof-of-principle preclinical study evaluated the efficacy, safety, and effect on survival of neoadjuvant intratumoral (in situ) empty cowpea mosaic virus (eCPMV) immunotherapy in companion dogs diagnosed with IMC.MethodsTen IMC-bearing dogs were enrolled in the study. Five dogs received medical therapy, and five received weekly neoadjuvant in situ eCPMV immunotherapy (0.2β0.4βmg per injection) and medical therapy after the second eCPMV injection. Efficacy was evaluated by reduction of tumor growth; safety by hematological and biochemistry changes in blood and plasma; and patient outcome by survival analysis. eCPMV-induced immune changes in blood cells were analyzed by flow cytometry; changes in the tumor microenvironment were evaluated by CD3 (T lymphocytes), CD20 (B lymphocytes), FoxP3 (Treg lymphocytes), myeloperoxidase (MPO; neutrophils), Ki-67 (proliferation index, PI; tumor cell proliferation), and Cleaved Caspase-3 (CC-3; apoptosis) immunohistochemistry.ResultsTwo neoadjuvant in situ eCPMV injections resulted in tumor shrinkage in all patients by day 14 without systemic adverse events. Although surgery for IMC is generally not an option, reduction in tumor size allowed surgery in two IMC patients. In peripheral blood, in situ eCPMV immunotherapy was associated with a significant decrease of Treg/CD8 ratio and changes in CD8Granzyme B T cells, which behave as a lagging predictive biomarker. In the TME, higher neutrophilic infiltration and MPO expression, lower tumor Ki-67 PI, increase in CD3 lymphocytes, decrease in FoxP3/CD3 ratio (p<0.04 for all comparisons), and no changes in CC-3 immunostainings were observed in post-treatment tumor tissues when compared with pretreatment tumor samples. eCPMV-treated IMC patients had a statistically significant (p=0.033) improved overall survival than patients treated with medical therapy.ConclusionsNeoadjuvant in situ eCPMV immunotherapy demonstrated anti-tumor efficacy and improved survival in IMC patients without systemic adverse effects. eCPMV-induced changes in immune cells point to neutrophils as a driver of immune response. Neoadjuvant in situ eCPMV immunotherapy could be a groundbreaking immunotherapy for canine IMC and a potential future immunotherapy for human IBC patients
Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients
The lack of optimal models to evaluate novel agents is delaying the development of effective immunotherapies against human breast cancer (BC). In this prospective open label study, we applied neoadjuvant intratumoral immunotherapy with empty cowpea mosaic virus-like particles (eCPMV) to 11 companion dogs diagnosed with canine mammary cancer (CMC), a spontaneous tumor resembling human BC. We found that two neoadjuvant intratumoral eCPMV injections resulted in tumor reduction in injected tumors in all patients and in noninjected tumors located in the ipsilateral and contralateral mammary chains of injected dogs. Tumor reduction was independent of clinical stage, tumor size, histopathologic grade, and tumor molecular subtype. RNA-seq-based analysis of injected tumors indicated a decrease in DNA replication activity and an increase in activated dendritic cell infiltration in the tumor microenvironment. Immunohistochemistry analysis demonstrated significant intratumoral increases in neutrophils, T and B lymphocytes, and plasma cells. eCPMV intratumoral immunotherapy demonstrated antitumor efficacy without any adverse effects. This novel immunotherapy has the potential for improving outcomes for human BC patients
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials
BACKGROUND: The aim of this study was to determine the activity of anthracycline rechallenge using pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) previously treated with conventional anthracyclines. METHODS: Pooled individual data from four prospective trials were used, and the primary end point of the pooled analysis was clinical benefit rate (CBR). The studies comprised 935 patients, of whom 274 had received PLD in the metastatic setting after prior exposure to conventional anthracyclines (rechallenge population). RESULTS: The majority of patients were heavily pretreated. Previous anthracycline therapy was administered in the adjuvant (14%) or metastatic setting (46%), or both (40%). The overall CBR from rechallenge with PLD was 37.2% (95% CI, 32.4-42.0). In univariate analyses, the CBR was significantly higher in patients with less exposure to prior chemotherapy, in taxane-naive patients, and in patients with a favourable Eastern Cooperative Group performance status of 0 vs 1 vs 2 (53.3 vs 35.5 vs 18.2%; P<0.001). In multivariate analyses, performance status proved to be the only independent predictor of the CBR achieved with PLD rechallenge (P=0.038). There was no statistically significant difference in CBR regarding the setting, cumulative dose of and/or resistance to prior anthracyclines, or time since prior anthracycline administration. CONCLUSION: Anthracycline rechallenge using PLD is effective in patients with MBC who have a favourable performance status, regardless of setting, resistance, cumulative dose or time since prior conventional anthracycline therapy. British Journal of Cancer (2010) 103, 1518-1523. doi:10.1038/sj.bjc.6605961 www.bjcancer.com Published online 26 October 2010 (C) 2010 Cancer Research U
From the Shell-shocked Soldier to the Nervous Child: Psychoanalysis in the Aftermath of the First World War
This article investigates the development of child analysis in Britain between the wars, as the anxious child succeeded the shell-shocked soldier as a focus of psychoanalytic enquiry. Historians of psychoanalysis tend to regard the Second World War as a key moment in the discovery of the βwar withinβ the child, but it was in the aftermath of the First War that the warring psyche of the child was observed and elaborated. The personal experience of war and its aftermath, and the attention given to regression in the treatment of war neuroses, encouraged Melanie Klein, Anna Freud and others to turn their attention to children. At the same time, however, the impact of the First World War as a traumatic event, with inter-generational consequences, remained largely unaccounted for within psychoanalysis as Klein and others focused on the child's riven internal world
- β¦